胰腺切除术后再入院的分类及针对性缓解策略的机会
在学习型医疗系统框架内,本研究评估再入院原因以识别改进机会。采用单机构病例对照研究,纳入2016年10月至2022年4月连续胰腺切除术患者835例,24%(204/835)发生再入院,主要原因为技术性(51%)、内科/代谢性(31%)和感染性(17%)。结论认为多数再入院为技术性起源,出院前风险分层和加强门诊资源可能降低再入院率。
要点
- 胰腺切除术后24%(204/835)患者发生再入院,技术性原因占51%(105/204)。
- 技术性和感染性再入院分别有77%(81/105)和60%(21/35)需要操作,内科/代谢性再入院66%(42/64)经非侵入性处理。
- 索引住院期间良性病理、生化胰漏、胆/胃/乳糜漏、器官间隙感染、影像未引流积液和白细胞升高与再入院独立相关。
核心结论
- 胰腺切除术后大多数再入院为技术性起源。
- 索引住院期间出现并发症、白细胞升高或出院前有未引流积液的患者再入院风险最高。
- 出院前对再入院风险因素进行风险分层并加强门诊资源可能是降低再入院率的策略。
研究设计与样本
- 单机构病例对照研究,纳入2016年10月至2022年4月连续接受胰腺切除术的患者835例。
- 并发症在每两周一次的教师和高级实践提供者会议上前瞻性分级。
- 分析索引住院期间的危险因素并对90天再入院的指征进行分类。
主要发现
- 835例患者中位年龄65岁,51%(427/835)为男性,64%(534/835)行胰十二指肠切除术,34%(280/835)行远端胰腺切除术,3%(21/835)行其他切除术。
- 24%(204/835)患者发生再入院,主要指征为技术性51%(105/204)、感染性17%(35/204)、内科/代谢性31%(64/204)。
- 技术性和感染性再入院分别有77%(81/105)和60%(21/35)需要操作,内科/代谢性再入院66%(42/64)经非侵入性处理。
- 索引住院期间良性病理(OR 1.8,P=0.049)、生化胰漏(OR 2.3,P=0.001)、胆/胃/乳糜漏(OR 6.4,P=0.001)、器官间隙感染(OR 3.4,P=0.007)、影像未引流积液(OR 2.4,P=0.045)和白细胞升高(OR 1.7,P=0.045)与再入院 odds 独立相关。
临床怎么用
- 出院前对再入院风险因素进行风险分层并加强门诊资源可能是降低再入院率的策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Within a learning health system paradigm, this study sought to evaluate reasons for readmission to identify opportunities for improvement. BACKGROUND: Post-pancreatectomy readmission rates have remained constant despite improved index hospitalization metrics. METHODS: We performed a single-institution case-control study of consecutive patients with pancreatectomy (October 2016 to April 2022). Complications were prospectively graded in biweekly faculty and advanced practice provider meetings. We analyzed risk factors during index hospitalization and categorized indications for 90-day readmissions. RESULTS: A total of 835 patients, median age 65 years and 51% (427/835) males, underwent 64% (534/835) pancreatoduodenectomies, 34% (280/835) distal pancreatectomies, and 3% (21/835) other resections. Twenty-four percent (204/835) of patients were readmitted. The primary indication for readmission was technical in 51% (105/204), infectious in 17% (35/204), and medical/metabolic in 31% (64/204) of patients. Procedures were required in 77% (81/105) and 60% (21/35) of technical and infectious readmissions, respectively, while 66% (42/64) of medical/metabolic readmissions were managed noninvasively. During the index hospitalization, benign pathology [odds ratio (OR): 1.8, P =0.049], biochemical pancreatic leak (OR: 2.3, P =0.001), bile/gastric/chyle leak (OR: 6.4, P =0.001), organ-space infection (OR: 3.4, P =0.007), undrained fluid on imaging (OR: 2.4, P =0.045), and increasing white blood cell count (OR: 1.7, P =0.045) were independently associated with odds of readmission. CONCLUSIONS: Most readmissions following pancreatectomy were technical in origin. Patients with complications during the index hospitalization, increasing white blood cell count, or undrained fluid before discharge were at the highest risk for readmission. Predischarge risk stratification of readmission risk factors and augmentation of in-clinic resources may be strategies to reduce readmission rates.
引用
- Boyev A, Azimuddin A, Prakash LR, et al. Classification of Post-pancreatectomy Readmissions and Opportunities for Targeted Mitigation Strategies. Ann Surg. 2023. PMID: 37791481. doi:10.1097/SLA.0000000000006112
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。